Ceredex Value Advisors LLC bought a new position in shares of Physicians Realty Trust (NYSE:DOC) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,404,498 shares of the real estate investment trust’s stock, valued at approximately $68,578,000. Ceredex Value Advisors LLC owned approximately 2.42% of Physicians Realty Trust as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also bought and sold shares of DOC. Brookfield Asset Management Inc. acquired a new stake in Physicians Realty Trust during the 4th quarter worth approximately $70,764,000. Cbre Clarion Securities LLC acquired a new stake in Physicians Realty Trust during the 4th quarter worth approximately $46,085,000. PGGM Investments increased its position in Physicians Realty Trust by 69.0% during the 4th quarter. PGGM Investments now owns 4,604,000 shares of the real estate investment trust’s stock worth $82,826,000 after purchasing an additional 1,880,000 shares in the last quarter. Wells Fargo & Company MN increased its position in Physicians Realty Trust by 35.6% during the 1st quarter. Wells Fargo & Company MN now owns 2,910,188 shares of the real estate investment trust’s stock worth $45,311,000 after purchasing an additional 763,414 shares in the last quarter. Finally, Citadel Advisors LLC increased its position in Physicians Realty Trust by 62.2% during the 4th quarter. Citadel Advisors LLC now owns 1,544,354 shares of the real estate investment trust’s stock worth $27,783,000 after purchasing an additional 592,125 shares in the last quarter. 93.01% of the stock is owned by hedge funds and other institutional investors.
In related news, Director Tommy G. Thompson purchased 13,650 shares of the firm’s stock in a transaction dated Tuesday, March 6th. The stock was acquired at an average price of $14.71 per share, with a total value of $200,791.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.51% of the stock is currently owned by company insiders.
Shares of NYSE:DOC opened at $14.60 on Friday. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.39 and a quick ratio of 1.39. Physicians Realty Trust has a 52-week low of $14.67 and a 52-week high of $14.95. The company has a market capitalization of $2.70 billion, a price-to-earnings ratio of 14.04, a PEG ratio of 3.11 and a beta of 0.46.
Physicians Realty Trust (NYSE:DOC) last issued its quarterly earnings data on Friday, May 4th. The real estate investment trust reported $0.06 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.27 by ($0.21). Physicians Realty Trust had a net margin of 11.46% and a return on equity of 1.75%. The firm had revenue of $105.20 million during the quarter, compared to analyst estimates of $101.70 million. During the same period last year, the business earned $0.28 EPS. The firm’s revenue was up 37.2% compared to the same quarter last year. analysts anticipate that Physicians Realty Trust will post 1.1 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, April 18th. Stockholders of record on Tuesday, April 3rd were given a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a dividend yield of 6.30%. The ex-dividend date of this dividend was Monday, April 2nd. Physicians Realty Trust’s payout ratio is currently 88.46%.
A number of analysts recently issued reports on the stock. BMO Capital Markets reissued a “buy” rating and set a $18.00 target price on shares of Physicians Realty Trust in a research report on Tuesday, March 27th. KeyCorp dropped their target price on shares of Physicians Realty Trust from $20.00 to $17.00 and set a “buy” rating for the company in a research report on Tuesday, April 17th. Cantor Fitzgerald reissued a “buy” rating and set a $18.00 target price on shares of Physicians Realty Trust in a research report on Monday, May 7th. Zacks Investment Research raised shares of Physicians Realty Trust from a “sell” rating to a “hold” rating in a research report on Wednesday, May 9th. Finally, Stifel Nicolaus set a $18.00 price objective on shares of Physicians Realty Trust and gave the company a “buy” rating in a research report on Thursday, March 1st. One analyst has rated the stock with a sell rating, seven have given a hold rating and ten have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $18.04.
Physicians Realty Trust Company Profile
Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare.
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Physicians Realty Trust (NYSE:DOC).
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.